Literature DB >> 304805

Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z.

J O Jeppsson, C B Laurell, M Fagerhol.   

Abstract

1. alpha1-Antitrypsin contains a single thiol group partly blocked in native plasma and reactive after mild reduction. 2. Human alpha1-antitrypsins of Pi types F, M, S and Z have been isolated with native microheterogeneity using thiol-disulfide (SH-SS) interchange reactions utilizing the reactive thiol group. 3. The pI of the various microheterogeneous fractions are given for protein M. Stepwise desialylation of alpha1-antitrypsin indicates that the charge difference between the major fractions is one sialic acid residue between each. This is further supported by the pI changes obtained on substitution of the single thiol with positively or negatively charged compounds. 4. Desialyation of purified proteins from each Pi type converts the individual microheterogeneous fractions to one major fraction. The pI shift for the variants studied indicate a difference of plus or minus one or two charge units between protein M and the variants. 5. A difference of one sialic acid residue was obtained for proteins M and Z by the thiobarbituric assay, but stepwise removal of sialic acid with neuraminidase revealed almost identical stepwise change of pattern of both proteins indicating the same number of sialic acid residues. 6. Electrofocusing has been used to identify CNBr fragments from proteins M, S and Z. 7. An amino acid substitution has been found to be located in one of the eight CNBr fragments, glutamic acid in protein M is substituted by lysine in protein Z. 8. The average concentration of alpha1-antityprsin in plasma from healthy males was found to be 1.32 g/1.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304805     DOI: 10.1111/j.1432-1033.1978.tb12078.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  33 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Posttranslational modification of alpha 1-antitrypsin (protease inhibitor) and alkaline phosphatase in the marsupial, Perameles gunnii.

Authors:  W B Sherwin
Journal:  Biochem Genet       Date:  1990-02       Impact factor: 1.890

3.  Rare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes.

Authors:  D W Cox; G D Billingsley
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

4.  Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.

Authors:  J A Carlson; B B Rogers; R N Sifers; H K Hawkins; M J Finegold; S L Woo
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

5.  Alpha 1-antitrypsin screening of 18-year-old men.

Authors:  T Sveger; P Mazodier
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

6.  Characterization of mutants of the vitamin D-binding protein/group-specific component: molecular evolution of GC*1A2 and GC*1A3, common in some Asian populations.

Authors:  I Yuasa; A Kofler; A Braun; K Umetsu; R Bichlmaier; S Kammerer; H Cleve
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 7.  Alpha-1-antitrypsin deficiency: a biological enigma.

Authors:  A G Bearn
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

8.  The SANT2 domain of the murine tumor cell DnaJ-like protein 1 human homologue interacts with alpha1-antichymotrypsin and kinetically interferes with its serpin inhibitory activity.

Authors:  Barbara Kroczynska; Christina M Evangelista; Shalaka S Samant; Ebrahim C Elguindi; Sylvie Y Blond
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

9.  Alpha 1-antitrypsin: apparent molecular weight heterogeneity shown by two-dimensional electrophoresis.

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

10.  The genetic polymorphism of alpha 2-HS glycoprotein: study by ultrathin-layer isoelectric focusing and immunoblot.

Authors:  B Boutin; S H Feng; P Arnaud
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.